Satoshi Oeda

1.7k total citations
37 papers, 651 citations indexed

About

Satoshi Oeda is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Satoshi Oeda has authored 37 papers receiving a total of 651 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Epidemiology, 32 papers in Hepatology and 4 papers in Surgery. Recurrent topics in Satoshi Oeda's work include Liver Disease Diagnosis and Treatment (30 papers), Hepatitis C virus research (20 papers) and Hepatitis B Virus Studies (12 papers). Satoshi Oeda is often cited by papers focused on Liver Disease Diagnosis and Treatment (30 papers), Hepatitis C virus research (20 papers) and Hepatitis B Virus Studies (12 papers). Satoshi Oeda collaborates with scholars based in Japan, Germany and Greece. Satoshi Oeda's co-authors include Yuichiro Eguchi, Hirokazu Takahashi, Takumi Akiyama, Keizo Anzai, Kenichi Tanaka, Shinji Iwane, Seiji Kawazoe, Keisuke Ario, Masato Yoneda and Taiga Otsuka and has published in prestigious journals such as Scientific Reports, Ultrasound in Medicine & Biology and Journal of Gastroenterology.

In The Last Decade

Satoshi Oeda

35 papers receiving 643 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Satoshi Oeda Japan 13 445 369 186 124 113 37 651
Nancy E. Aguilar-Olivos Mexico 14 301 0.7× 232 0.6× 202 1.1× 109 0.9× 80 0.7× 24 523
Masaharu Ando Japan 15 424 1.0× 403 1.1× 216 1.2× 38 0.3× 100 0.9× 41 695
Naoto Kawabe Japan 14 402 0.9× 385 1.0× 103 0.6× 95 0.8× 52 0.5× 46 579
Aliya Gulamhusein Canada 15 561 1.3× 670 1.8× 506 2.7× 239 1.9× 174 1.5× 39 980
Tokio Higaki Japan 16 287 0.6× 451 1.2× 303 1.6× 217 1.8× 122 1.1× 75 691
Kyosuke Kaji Japan 14 206 0.5× 235 0.6× 151 0.8× 99 0.8× 82 0.7× 22 509
Masamichi Moriguchi Japan 16 210 0.5× 376 1.0× 285 1.5× 201 1.6× 132 1.2× 53 595
Nicola Alessi Italy 11 487 1.1× 421 1.1× 78 0.4× 43 0.3× 25 0.2× 21 642
Katsuhisa Nakatsuka Japan 14 340 0.8× 338 0.9× 195 1.0× 77 0.6× 49 0.4× 27 577
Kenta Takaura Japan 15 424 1.0× 387 1.0× 42 0.2× 32 0.3× 55 0.5× 41 564

Countries citing papers authored by Satoshi Oeda

Since Specialization
Citations

This map shows the geographic impact of Satoshi Oeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoshi Oeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoshi Oeda more than expected).

Fields of papers citing papers by Satoshi Oeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoshi Oeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoshi Oeda. The network helps show where Satoshi Oeda may publish in the future.

Co-authorship network of co-authors of Satoshi Oeda

This figure shows the co-authorship network connecting the top 25 collaborators of Satoshi Oeda. A scholar is included among the top collaborators of Satoshi Oeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoshi Oeda. Satoshi Oeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miura, Kouichi, Hideki Hayashi, Yoshihiro Kamada, et al.. (2023). Agile 3+ and Agile 4, noninvasive tests for liver fibrosis, are excellent formulae to predict liver‐related events in nonalcoholic fatty liver disease. Hepatology Research. 53(10). 978–988. 12 indexed citations
2.
Hayashi, Hideki, Yoshihiro Kamada, Hideki Fujii, et al.. (2023). Prediction of Liver-Related Events With a Combination of Liver Stiffness Measurements and Controlled Attenuation Parameters in Japanese Patients With Biopsy-Proven Non-alcoholic Fatty Liver Disease. Ultrasound in Medicine & Biology. 49(7). 1658–1664. 6 indexed citations
3.
Kobayashi, Takashi, Yuji Ogawa, Michihiro Iwaki, et al.. (2022). A 3-step approach to predict advanced fibrosis in nonalcoholic fatty liver disease: impact on diagnosis, patient burden, and medical costs. Scientific Reports. 12(1). 18174–18174. 3 indexed citations
4.
Tanaka, Kenichi, Rasheda Perveen, Wataru Yoshioka, et al.. (2022). HSPA8 Single-Nucleotide Polymorphism Is Associated with Serum HSC70 Concentration and Carotid Artery Atherosclerosis in Nonalcoholic Fatty Liver Disease. Genes. 13(7). 1265–1265. 5 indexed citations
5.
Tanaka, Kenichi, Satoshi Oeda, Kaori Inoue, et al.. (2021). Effect of skin–capsular distance on controlled attenuation parameter for diagnosing liver steatosis in patients with nonalcoholic fatty liver disease. Scientific Reports. 11(1). 15641–15641. 6 indexed citations
6.
Sumida, Yoshio, Masashi Yoneda, Yuya Seko, et al.. (2020). Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease. Diagnostics. 10(8). 579–579. 23 indexed citations
7.
Takahashi, Hirokazu, Shinji Iwane, Kanako Inoue, et al.. (2020). FIB-4 index-based surveillance for advanced liver fibrosis in diabetes patients. Diabetology International. 12(1). 118–125. 11 indexed citations
10.
Oeda, Satoshi, Hirokazu Takahashi, Hiroshi Isoda, et al.. (2019). Infection phase is a predictor of pruritus in patients with hepatitis B virus infection. Biomedical Reports. 11(2). 63–69. 2 indexed citations
11.
Kakiuchi, Toshihiko, et al.. (2016). The recognition of the hepatitis virus test and hepatitis B vaccine in prenatal checkup. Kanzo. 57(8). 376–381.
12.
13.
Kawaguchi, Yasunori, Satoshi Oeda, Toshihiko Mizuta, et al.. (2013). Current management practices for HBs antigen or anti-HCV antibody positive individuals in non-hepatology departments at a university hospital. Kanzo. 54(5). 307–316. 14 indexed citations
14.
Kuwashiro, Takuya, Toshihiko Mizuta, Yasunori Kawaguchi, et al.. (2013). Impairment of health-related quality of life in patients with chronic hepatitis C is associated with insulin resistance. Journal of Gastroenterology. 49(2). 317–323. 6 indexed citations
15.
Oeda, Satoshi, Toshihiko Mizuta, Hiroshi Isoda, et al.. (2013). Survival advantage of radiofrequency ablation for hepatocellular carcinoma: comparison with ethanol injection.. PubMed. 60(126). 1399–404. 10 indexed citations
16.
Otsuka, Taiga, Seiji Kawazoe, Shunya Nakashita, et al.. (2012). Low-dose rectal diclofenac for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a randomized controlled trial. Journal of Gastroenterology. 47(8). 912–917. 106 indexed citations
17.
Takahashi, Kazuhiro, Toshihiko Mizuta, Satoshi Oeda, et al.. (2012). An automated rapid detection system using the quenching probe method for detecting interleukin 28B and inosine triphosphatase single nucleotide polymorphisms in chronic hepatitis C. Journal of Viral Hepatitis. 20(4). e124–6. 6 indexed citations
18.
Takahashi, Kazuhiro, Toshihiko Mizuta, Yuichiro Eguchi, et al.. (2011). Post-challenge hyperglycemia is a significant risk factor for the development of hepatocellular carcinoma in patients with chronic hepatitis C. Journal of Gastroenterology. 46(6). 790–798. 33 indexed citations
19.
Takahashi, Kazuhiro, Toshihiko Mizuta, Seiji Kawazoe, et al.. (2010). Efficacy and safety of radiofrequency ablation for elderly hepatocellular carcinoma patients. Hepatology Research. 40(10). 997–1005. 55 indexed citations
20.
Kawaguchi, Yasunori, Toshihiko Mizuta, Takuya Kuwashiro, et al.. (2010). Metabolic factors are associated with serum alanine aminotransferase levels in patients with chronic hepatitis C. Journal of Gastroenterology. 46(4). 529–535. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026